Supraventricular tachycardia--part I

Current Problems in Cardiology
Ken W LeeM M Scheinman

Abstract

Supraventricular tachycardias (SVTs) affect all age groups and are a source of significant morbidity. They are frequently encountered in otherwise healthy individuals without structural heart disease. Advances in the understanding of their mechanisms and anatomical locations have led to highly effective pharmacologic and nonpharmacologic treatment strategies. Recognition, identification, and differentiation of the various SVTs are of great importance in formulating an effective treatment strategy. Developments over the past four decades have made possible the accurate diagnosis of SVTs. Today, advances in catheter design, energy delivery systems, mapping systems, and remote navigation systems have rendered the ablation of most SVTs safe and effective. This monograph provides an in-depth discussion of the history, presentation, mechanism, and treatment strategies of the most commonly encountered SVTs. The monograph is divided into two parts. The first part is presented here.

References

Jan 1, 1978·Progress in Cardiovascular Diseases·J J GallagherA G Wallace
Aug 1, 1979·Annals of Internal Medicine·D G BendittJ J Gallagher
Nov 15, 1979·The New England Journal of Medicine·G J KleinJ J Gallagher
Oct 1, 1977·The American Journal of Cardiology·R W CampbellA G Wallace
Nov 1, 1976·Circulation·B N GoldreyerK L Kershbaum
Oct 1, 1975·British Heart Journal·P DenesK M Rosen
Dec 1, 1975·American Heart Journal·W J MandelW Daley
Aug 1, 1992·Pacing and Clinical Electrophysiology : PACE·M D LeshT A Ports
Nov 1, 1992·The American Journal of Cardiology·L M RodriguezH J Wellens
Jun 13, 1992·JAMA : the Journal of the American Medical Association·R L LevineP A Clark
Aug 1, 1991·Pacing and Clinical Electrophysiology : PACE·D T ConnellyD Cunningham
Oct 1, 1991·Pacing and Clinical Electrophysiology : PACE·M D LeshM M Scheinman
Feb 15, 1992·The American Journal of Cardiology·M HaissaguerreJ F Warin
Jan 1, 1987·Pacing and Clinical Electrophysiology : PACE·F MoradyW Cline
May 1, 1987·Pacing and Clinical Electrophysiology : PACE·S MilsteinG J Klein
Mar 1, 1989·Pacing and Clinical Electrophysiology : PACE·M SatohA Shibata
Dec 1, 1989·Journal of the American College of Cardiology·A W HamerJ A Johns

❮ Previous
Next ❯

Citations

May 9, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·András Vereckei, John M Miller
Apr 18, 2014·European Journal of Pediatrics·Nicole SekarskiYvan Mivelaz
Dec 3, 2013·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Pasquale SantangeliAndrea Natale
May 13, 2009·Expert Opinion on Drug Safety·Knut Gjesdal
Jun 28, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Mark S LinkSumeet S Chugh
Aug 13, 2014·Case Reports in Medicine·S MarrakchiS Kachboura
Oct 30, 2016·Pharmacogenomics·Jason D Roberts, Gregory M Marcus
Jan 18, 2017·Pacing and Clinical Electrophysiology : PACE·Ryan T KippKurt S Hoffmayer
Aug 29, 2018·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Rebecca Vicente SteijnOndrej Nanka
Jan 17, 2020·Clinical Medicine : Journal of the Royal College of Physicians of London·Irum D KotadiaMark O'Neill
Feb 1, 2020·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Jens HartmannChristian Meyer
Aug 27, 2021·HeartRhythm Case Reports·Khalil KanjwalRonald D Berger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.